Clinical Trial: Impact of Using the Mylife CamAPS FX System Combined With the DEXCOM G6 Sensor on Glycemic Control and Quality of Life in Real-life Type 1 Diabetes Melitus Patients in France

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07048795) titled 'Impact of Using the Mylife CamAPS FX System Combined With the DEXCOM G6 Sensor on Glycemic Control and Quality of Life in Real-life Type 1 Diabetes Melitus Patients in France' on June 24.

Brief Summary: This is a non-interventional, longitudinal, prospective, multicenter, post market-registration and national study conducted in France. The study is conducted among participants with type 1 diabetes (T1D) using the mylife CamAPS FX hybrid closed-loop insulin delivery system combined with the DEXCOM G6 Continuous Glucose Monitoring (CGM) sensor (the System).

The main objective of the study is to evaluate, under real-life conditions, th...